Will Stone
Will Stone is a former reporter at KUNR Public Radio.
-
Get the first vaccine you're offered: that's the public health message. Each COVID-19 vaccine is highly effective at preventing severe disease, but some Americans want to choose the vaccine they get.
-
At least a dozen states have now seen an increase in COVID-19 hospitalizations. Epidemiologists explain what they think is behind the potential fourth surge of the pandemic in the U.S.
-
The possibility that vaccines meant to prevent the disease may also be a treatment for long COVID — when symptoms linger for months — has sparked optimism among patients and scientists.
-
An estimated 10% to 30% of people who get COVID-19 don't fully recover, but have chronic symptoms. Now some of these "long-haulers" are finding relief after getting the COVID-19 vaccine.
-
Researchers have quantified the price paid for fast-spreading COVID-19 infections. Patients who might have survived otherwise perished in crowded ICUs.
-
The Aldaco family of Phoenix suffered more than most in this year of unfathomable losses. Three brothers perished in the pandemic: Jose in July, Heriberto in December and Gonzalo in February.
-
As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over.
-
People in a diverse Seattle neighborhood consider the new Johnson & Johnson vaccine, particularly who is and isn't getting it and why.
-
Federal agents and others have seized more than 11 million counterfeit masks, including the N95 masks used in hospitals. What are some indicators of a fake mask?
-
The country has beat back the winter surge, and experts credit Americans' improved compliance with precautions like mask-wearing. But we could we still face a resurgence if we let up.